BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Treatment
155 results:

  • 1. Long non-coding RNA sox2OT in tamoxifen-resistant breast cancer.
    Lee J; Kim EA; Kang J; Chae YS; Park HY; Kang B; Lee SJ; Lee IH; Park JY; Park NJ; Jung JH
    BMC Mol Cell Biol; 2024 Apr; 25(1):12. PubMed ID: 38649821
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hinokitiol Inhibits breast cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/sox2/Oct4 Pathway.
    Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Estrogen-Related Receptor Alpha (ERRα) Promotes cancer Stem Cell-Like Characteristics in breast cancer.
    Muduli K; Prusty M; Pradhan J; Samal AP; Sahu B; Roy DS; Reddy KS; Elangovan S
    Stem Cell Rev Rep; 2023 Nov; 19(8):2807-2819. PubMed ID: 37584854
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Overexpression of sox2 Gene by Histone Modifications: sox2 Enhances Human Prostate and breast cancer Progression by Prevention of Apoptosis and Enhancing Cell Proliferation.
    Kar S; Niharika ; Roy A; Patra SK
    Oncology; 2023; 101(9):591-608. PubMed ID: 37549026
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A phenol amine molecule from Salinivenus iranica acts as the inhibitor of cancer stem cells in breast cancer cell lines.
    Safarpour A; Ebrahimi M; Fazeli SAS; Amoozegar MA
    Sci Rep; 2023 Aug; 13(1):12669. PubMed ID: 37542193
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The deformation of cancer cells through narrow micropores holds the potential to regulate genes that impact cancer malignancy.
    Choi JS; Lee SH; Park HB; Chun C; Kim Y; Kim KH; Weon BM; Kim DH; Kim HJ; Lee JH
    Lab Chip; 2023 Aug; 23(16):3628-3638. PubMed ID: 37448298
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative breast cancer MDA-MB-231 Cells.
    Pratelli G; Carlisi D; Di Liberto D; Notaro A; Giuliano M; D'Anneo A; Lauricella M; Emanuele S; Calvaruso G; De Blasio A
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446326
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
    Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
    J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance.
    Das S; Kundu M; Hassan A; Parekh A; Jena BC; Mundre S; Banerjee I; Yetirajam R; Das CK; Pradhan AK; Das SK; Emdad L; Mitra P; Fisher PB; Mandal M
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166702. PubMed ID: 37044238
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces cancer Stem Cells in Triple Negative breast cancer.
    Bano A; Stevens JH; Modi PS; Gustafsson JÅ; Strom AM
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982940
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC.
    Marni R; Malla M; Chakraborty A; Malla R
    Life Sci; 2023 May; 320():121534. PubMed ID: 36889667
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tumour necrosis factor stimulated gene 6 intrinsically regulates PD-L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment.
    Lee JH; An JH; Youn HY
    Vet Comp Oncol; 2023 Jun; 21(2):255-269. PubMed ID: 36807440
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An explorative study for leveraging transcriptomic data of embryonic stem cells in mining cancer stemness genes, regulators, and networks.
    Yang J; Xu H; Li C; Li Z; Hu Z
    Math Biosci Eng; 2022 Sep; 19(12):13949-13966. PubMed ID: 36654075
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway.
    Liao Y; Luo Z; Liu Y; Xue W; He S; Chen X; Ren H; Yang X; Zhu D; Su Z; Huang Q; Guo H
    J Ethnopharmacol; 2023 Apr; 305():116133. PubMed ID: 36603788
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. sox2-high cancer cells exhibit an aggressive phenotype, with increases in stemness, proliferation and invasion, as well as higher metabolic activity and ATP production.
    Mauro-Lizcano M; Sotgia F; Lisanti MP
    Aging (Albany NY); 2022 Dec; 14(24):9877-9889. PubMed ID: 36566021
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer.
    Panoutsopoulou K; Liu Y; Avgeris M; Dreyer T; Dorn J; Magdolen V; Scorilas A
    Clin Biochem; 2023 Apr; 114():43-51. PubMed ID: 36502883
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Thymoquinone-treated mouse mesenchymal stem cells-derived conditioned medium inhibits human breast cancer cells in vitro.
    Hajmomeni P; Sisakhtnezhad S; Bidmeshkipour A
    Chem Biol Interact; 2023 Jan; 369():110283. PubMed ID: 36450322
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer?
    Rajabi N; Mohammadnejad F; Doustvandi MA; Shadbad MA; Amini M; Tajalli H; Mokhtarzadeh A; Baghbani E; Silvestris N; Baradaran B
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103212. PubMed ID: 36436735
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. GDF15 Contributes to Radioresistance by Mediating the EMT and Stemness of breast cancer Cells.
    Zhao X; Liu X; Hu S; Pan Y; Zhang J; Tai G; Shao C
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142823
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets
    Zhou C; Wang D; Li J; Wang Q; Wo L; Zhang X; Hu Z; Wang Z; Zhan M; He M; Hu G; Chen X; Shen K; Chen GQ; Zhao Q
    Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2117988119. PubMed ID: 36126099
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.